Clinical Trial Update: Efficacy Study of Glyceryl-Trinitrate Patch and Parecoxib (Valdecoxib) for the Prevention of Pancreatitis After Endoscopic Retrograde Cholangiopancreatography (ERCP) [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 trial evaluating whether a glyceryl trinitrate patch plus parecoxib can prevent pancreatitis after ERCP was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatitis
• Post-ercp Pancreatitis

Drugs mentioned

• Glyceryl-trinitrate patch (glyceryl trinitrate)
• Parecoxib (parecoxib)

Snippet

Sponsor: All India Institute of Medical Sciences | Conditions: ERCP, Pancreatitis | Phase 2, Phase 3 | Status: TERMINATED